反応式
[C:1]1([C:7]2[CH:11]=[C:10]([C:12]3[CH:17]=[CH:16][CH:15]=[CH:14][CH:13]=3)[N:9]([CH2:18][C:19](O)=[O:20])[N:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.CCN(C(C)C)C(C)C.[N:53]1([C:59]2[N:64]=[CH:63][CH:62]=[CH:61][N:60]=2)[CH2:58][CH2:57][NH:56][CH2:55][CH2:54]1.[OH-].[Na+]>CN(C=O)C.C(Cl)Cl>[C:1]1([C:7]2[CH:11]=[C:10]([C:12]3[CH:13]=[CH:14][CH:15]=[CH:16][CH:17]=3)[N:9]([CH2:18][C:19]([N:56]3[CH2:57][CH2:58][N:53]([C:59]4[N:60]=[CH:61][CH:62]=[CH:63][N:64]=4)[CH2:54][CH2:55]3)=[O:20])[N:8]=2)[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1参加物
8
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
278 mg (3,5-diphenyl-pyrazol-1-yl)-acetic acid was dissolved in 5 mL DMF. 321 mg TBTU and 172 μL DIPEA were added to this solution and the mixture was stirred for a few minutes at RT. 164 mg 2-(1-piperazinyl)-pyrimidine was added and stiffing was continued for 30 min. Then 10 mL of a 1M NaOH solution and 50 mL CH2Cl2 were added, the organic phase was separated. The solvent was removed and the residue was purified by flash chromatography (silica gel, DCM/MeOH/NH3 0-5%). Diethylether was given to the residue and the precipitate was filtered to yield 310 mg of the desired compound.
後処理
- customthe organic phase was separated
- customThe solvent was removed
- customthe residue was purified by flash chromatography (silica gel, DCM/MeOH/NH3 0-5%)
- filtrationthe precipitate was filtered
出典と根拠
- ORDレコード
- ord-49b5a83dc13b4d57b96ba0b47e36f155
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08822464B2
関連ノート
読み込み中…